WEST PHARMACEUTICAL SERVICES INC (WST) Form 8-K — Oct 26, 2026
$WSTForm 8-KItems 1.01, 1.02, 2.03, 9.01Filed Oct 26, 2026, 5:14 PM ET0000105770-26-000114Original filing
West Pharmaceutical Services entered into a new five-year credit agreement on October 26, 2026, providing a $750 million unsecured revolving credit facility and a $200 million term loan with Bank of America as administrative agent. The company used part of the proceeds to repay the $130.0 million outstanding under its 2019 credit agreement and terminated that facility without early termination penalties.
Key figures
- Debt Amount
- $950,000,000 total commitments ($750 million revolving, $200 million term loan)
- Maturity Date
- October 26, 2031
- Commitment fee
- 0.125%-0.225%
- Swing line sublimit
- $90 million
- Revolver margin sofr
- 1.000%-1.500%
- Net leverage covenant
- 3.50:1.00 (4.00:1.00 during material acquisition periods)
- Term loan margin sofr
- 1.125%-1.750%
- Existing credit repaid
- $130.0 million
- Letter of credit sublimit
- $50 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.